Name: VERTEX PHARMACEUTICALS INC (VRTX) Stock
Brand: VERTEX PHARMACEUTICALS INC
Rating: 7 (3 reviews)

VRTX Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Chartmill

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Emerges as a Top Affordable Growth Stock

17 days ago - By: Chartmill

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Shows Strong Fundamentals and Bullish Technical Setup

a day ago - By: Benzinga - Mentions: AZN HUM UNH REPL ...

10 Health Care Stocks With Whale Alerts In Today's Session

4 days ago - By: Zacks Investment Research - Mentions: ALKS CRMD CRSP

CRSP Posts Narrower-Than-Expected Loss in Q3, Sales Miss Estimates

7 days ago - By: Vertex Pharmaceuticals Incorporated

Vertex Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at American Society of Nephrology Kidney Week

8 days ago - By: Benzinga - Mentions: GSK JNJ LLY NVO

FDA Fast-Tracks 6 More Drugs - Obesity And Cancer Drugs Included

8 days ago - By: Zacks Investment Research

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

10 days ago - By: Zacks Investment Research - Mentions: ANIP NTLA CRSP

VRTX's New Drugs Performance Mixed in Q3: Can Their Sales Improve?

11 days ago - By: Zacks Investment Research - Mentions: ANIP NTLA CRSP

Vertex Q3 Earnings Beat, Stock Down as Casgevy Sales Disappoint

12 days ago - By: Zacks Investment Research

Vertex (VRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

12 days ago - By: Zacks Investment Research - Mentions: CGEN

Vertex Pharmaceuticals (VRTX) Q3 Earnings and Revenues Top Estimates

12 days ago - By: Investor's Business Daily

Vertex Pharma Dips Despite Quarterly Beat And Slight Guidance Book

12 days ago - By: Bloomberg

Vertex Beats Estimates on Strong Sales of Cystic Fibrosis Drugs

12 days ago - By: Vertex Pharmaceuticals Incorporated

Vertex Reports Third Quarter 2025 Financial Results

12 days ago - By: Zacks Investment Research - Mentions: BEAM NTLA CRSP

Should CRSP Stock Be in Your Portfolio Pre-Q3 Earnings?

12 days ago - By: The Motley Fool - Mentions: PFE

2 Healthcare Stocks for Individual Investors With a 20-Year Time Horizon

12 days ago - By: The Motley Fool - Mentions: NFLX

Inflation-Proof Investing: Which Growth Stock Will Double Your Money in 6 Years?

15 days ago - By: Zacks Investment Research - Mentions: RIGL ANIP EXAS

Rigel Gears Up to Report Q3 Earnings: Here's What to Expect

17 days ago - By: Zacks Investment Research

Vertex Pharmaceuticals (VRTX) Stock Moves -1.23%: What You Should Know

17 days ago - By: Zacks Investment Research - Mentions: ALNY ZTS EXAS

Zoetis Gears Up to Report Q3 Earnings: Here's What to Expect